It was interesting that nothing was mentioned about nnz2591 for Rett syndrome in the presentation.
I am confident the company is underplaying their hand for obvious reasons
- Forums
- ASX - By Stock
- Ann: DAYBUE (trofinetide) 2024 net sales US$348 million
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.44%
!
$12.60

It was interesting that nothing was mentioned about nnz2591 for...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.60 |
Change
0.055(0.44%) |
Mkt cap ! $1.551B |
Open | High | Low | Value | Volume |
$12.61 | $12.68 | $12.32 | $5.655M | 453.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 262 | $12.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.60 | 694 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 1031 | 12.550 |
12 | 917 | 12.540 |
11 | 1407 | 12.530 |
4 | 1323 | 12.520 |
5 | 1406 | 12.510 |
Price($) | Vol. | No. |
---|---|---|
12.570 | 190 | 4 |
12.580 | 183 | 2 |
12.590 | 1916 | 8 |
12.600 | 1981 | 7 |
12.610 | 1898 | 5 |
Last trade - 15.41pm 25/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |